A Newborn with Congenital Hyperinsulinism having a Novel Homozygous Mutation in the ABCC8 Gene
Journal: International Journal of Science and Research (IJSR) (Vol.5, No. 8)Publication Date: 2016-08-05
Authors : Pritesh Patel; Pooja Patel; Sachin Shah;
Page : 894-896
Keywords : ABCC8; Novel mutation; Refractory hypoglycemia; congenital hyperinsulinism; Octreotide;
Abstract
Congenital hyperinsulinism (CHI) is the most common cause of persistent hypoglycemia in newborns and infants. It is characterized by the unregulated secretion of insulin from pancreatic B- cells in relation to blood glucose concentration. We reported the case of full term, appropriate for gestational age newborn suffered from CHI and developed severe and persistent hypoglycemia which unresponsive to medical treatments including diazoxide, octreotide, Nifedipine. Somatostatin receptor PET -CT, Addendum to 68Ga Dotatate PET -CT scan showed mild diffuse somatostatin receptor expression is seen in the entire pancreas and focal increased uptake in liver segment IVb and V. The patient was confirmed to have a novel ABCC8 homozygous mutation at c.1335_1364del position.
Other Latest Articles
- Design of Micro Strip Patch Antenna for Ku Band Applications by Using Hybrid Algorithms
- Time Lapse between Initial Stroke Symptoms to Performance of CT Scan in Patients with Ischemic Stroke in Pakistan
- Multiple Arterial Thrombosis in Anti Thrombin III Deficiency
- Seismic Analysis of Steel Concrete Composite System and its Contrast with RCC Structures
- Role of Upper GI Scopy in Preventing Postcholecystectomy Pain in Patients with Cholelithiasis
Last modified: 2021-07-01 14:42:41